These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36811291)

  • 1. Impact of COVID-19 infection on cognition and its association with neurological symptoms.
    Almeria M; Cejudo JC; Sanz-Santos J; Deus J; Krupinski J
    Brain Behav; 2023 Apr; 13(4):e2902. PubMed ID: 36811291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive and Neuropsychiatric Sequelae in Long COVID-19 Infection.
    Almeria M; Cejudo JC; Deus J; Krupinski J
    Brain Sci; 2024 Jun; 14(6):. PubMed ID: 38928604
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment.
    Almeria M; Cejudo JC; Sotoca J; Deus J; Krupinski J
    Brain Behav Immun Health; 2020 Dec; 9():100163. PubMed ID: 33111132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective and subjective cognition in survivors of COVID-19 one year after ICU discharge: the role of demographic, clinical, and emotional factors.
    Godoy-González M; Navarra-Ventura G; Gomà G; de Haro C; Espinal C; Fortià C; Ridao N; Miguel Rebanal N; Oliveras-Furriols L; Subirà C; Jodar M; Santos-Pulpón V; Sarlabous L; Fernández R; Ochagavía A; Blanch L; Roca O; López-Aguilar J; Fernández-Gonzalo S
    Crit Care; 2023 May; 27(1):188. PubMed ID: 37189173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive Profiles in Patients With Persisting Cognitive Symptoms Associated With COVID-19.
    Krishnan K; Miller AK; Reiter K; Bonner-Jackson A
    Arch Clin Neuropsychol; 2022 May; 37(4):729-737. PubMed ID: 35136912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.
    Fett AJ; Velthorst E; Reichenberg A; Ruggero CJ; Callahan JL; Fochtmann LJ; Carlson GA; Perlman G; Bromet EJ; Kotov R
    JAMA Psychiatry; 2020 Apr; 77(4):387-396. PubMed ID: 31825511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 severity is related to poor executive function in people with post-COVID conditions.
    Ariza M; Cano N; Segura B; Adan A; Bargalló N; Caldú X; Campabadal A; Jurado MA; Mataró M; Pueyo R; Sala-Llonch R; Barrué C; Bejar J; Cortés CU; ; Garolera M; Junqué C
    J Neurol; 2023 May; 270(5):2392-2408. PubMed ID: 36939932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Complaints Assessment and Neuropsychiatric Disorders After Mild COVID-19 Infection.
    Hammerle MB; Sales DS; Pinheiro PG; Gouvea EG; de Almeida PIFM; de Araujo Davico C; Souza RS; Spedo CT; Nicaretta DH; Alvarenga RMP; Pires KL; Thuler LCS; Vasconcelos CCF
    Arch Clin Neuropsychol; 2023 Feb; 38(2):196-204. PubMed ID: 36464245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological deficits in patients with cognitive complaints after COVID-19.
    García-Sánchez C; Calabria M; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Lleó A; Alcolea D; Belvís R; Morollón N; Mur I; Pomar V; Domingo P
    Brain Behav; 2022 Mar; 12(3):e2508. PubMed ID: 35137561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurologic and cognitive sequelae after SARS-CoV2 infection: Different impairment for ICU patients.
    Mattioli F; Piva S; Stampatori C; Righetti F; Mega I; Peli E; Sala E; Tomasi C; Indelicato AM; Latronico N; De Palma G
    J Neurol Sci; 2022 Jan; 432():120061. PubMed ID: 34894422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairments and mental health of patients with post-COVID-19: A cross-sectional study.
    Morawa E; Krehbiel J; Borho A; Herold R; Lieb M; Schug C; Erim Y
    J Psychosom Res; 2023 Oct; 173():111441. PubMed ID: 37544160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning.
    Whiteside DM; Basso MR; Naini SM; Porter J; Holker E; Waldron EJ; Melnik TE; Niskanen N; Taylor SE
    Clin Neuropsychol; 2022 May; 36(4):806-828. PubMed ID: 35130818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological symptoms and findings in COVID-19: a prospective clinical study.
    Köseoğlu Toksoy C; Yavuz T; Orhan S; Şarlak Konya P; Korkmaz D; Tünay H; Bozkurt E; Coşğun İG; Demirtürk N; Doğan İ; Türk Börü Ü
    Neurol Res; 2022 Jan; 44(1):1-6. PubMed ID: 34269161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of cognitive dysfunction one-year post COVID-19.
    Cavaco S; Sousa G; Gonçalves A; Dias A; Andrade C; Pereira D; Aires EA; Moura J; Silva L; Varela R; Malheiro S; Oliveira V; Teixeira-Pinto A; Maia LF; Correia M
    Neuropsychology; 2023 Jul; 37(5):557-567. PubMed ID: 36603126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cognitive functioning is impaired in ICU-treated COVID-19 patients: a comprehensive controlled neuropsychological study.
    Ollila H; Pihlaja R; Koskinen S; Tuulio-Henriksson A; Salmela V; Tiainen M; Hokkanen L; Hästbacka J
    Crit Care; 2022 Jul; 26(1):223. PubMed ID: 35858899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
    Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
    Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
    ; Morin L; Savale L; Pham T; Colle R; Figueiredo S; Harrois A; Gasnier M; Lecoq AL; Meyrignac O; Noel N; Baudry E; Bellin MF; Beurnier A; Choucha W; Corruble E; Dortet L; Hardy-Leger I; Radiguer F; Sportouch S; Verny C; Wyplosz B; Zaidan M; Becquemont L; Montani D; Monnet X
    JAMA; 2021 Apr; 325(15):1525-1534. PubMed ID: 33729425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.